z-logo
open-access-imgOpen Access
Macrophages inhibit Aspergillus fumigatus germination and neutrophil-mediated fungal killing
Author(s) -
Emily E. Rosowski,
Nicholas Raffa,
Benjamin P. Knox,
Netta Golenberg,
Nancy P. Keller,
Anna Huttenlocher
Publication year - 2018
Publication title -
plos pathogens
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.719
H-Index - 206
eISSN - 1553-7374
pISSN - 1553-7366
DOI - 10.1371/journal.ppat.1007229
Subject(s) - aspergillus fumigatus , microbiology and biotechnology , biology , virulence , immune system , macrophage , in vivo , immunology , in vitro , gene , biochemistry
In immunocompromised individuals, Aspergillus fumigatus causes invasive fungal disease that is often difficult to treat. Exactly how immune mechanisms control A . fumigatus in immunocompetent individuals remains unclear. Here, we use transparent zebrafish larvae to visualize and quantify neutrophil and macrophage behaviors in response to different A . fumigatus strains. We find that macrophages form dense clusters around spores, establishing a protective niche for fungal survival. Macrophages exert these protective effects by inhibiting fungal germination, thereby inhibiting subsequent neutrophil recruitment and neutrophil-mediated killing. Germination directly drives fungal clearance as faster-growing CEA10-derived strains are killed better in vivo than slower-growing Af293-derived strains. Additionally, a CEA10 pyrG -deficient strain with impaired germination is cleared less effectively by neutrophils. Host inflammatory activation through Myd88 is required for killing of a CEA10-derived strain but not sufficient for killing of an Af293-derived strain, further demonstrating the role of fungal-intrinsic differences in the ability of a host to clear an infection. Altogether, we describe a new role for macrophages in the persistence of A . fumigatus and highlight the ability of different A . fumigatus strains to adopt diverse modes of virulence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here